Retail investor discussions across popular Reddit communities regarding Ocugen, Inc. (OCGN) frequently reflect a speculative and highly polarized sentiment characteristic of micro-cap biotechnology equities. While optimistic retail traders frequently highlight the massive percentage upside implied by Wall Street price targets and potential breakthroughs in gene therapy as reasons for bullish accumulation, more cautious community members emphasize the inherent risks of clinical trial volatility, potential shareholder dilution, and prolonged pre-revenue timelines.